Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Clinical trial NCT05955365 · RECRUITING

Trial details

NCT number: NCT05955365
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Percutaneous Coronary Intervention (PCI)Atrial Fibrillation (AF)Oral Anticoagulation P2Y12 Inhibitor

Start date: 2023-12-18
Primary completion: 2027-12-31
Enrollment: 3010

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.